Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 7786 AL 7800

Is the pathology of posterior cortical atrophy clinically predictable?

Cipriano L, Oliva M, Puoti G, Signoriello E, Bonavita S, Coppola C.

Rev Neurosci. 2022 Jun 6;33(8):849-858. doi: 10.1515/revneuro-2022-0003. Print 2022 Dec 16.

A clinicopathological study of selected cognitive impairment cases in Lothian, Scotland: enhanced CJD surveillance in the 65 + population group

Kanguru L, Logan G, Waddel B, Smith C, Molesworth A, Knight R.

BMC Geriatr. 2022 Jul 20;22(1):603. doi: 10.1186/s12877-022-03280-4.

Shift of musical hallucinations to visual hallucinations after correction of the hearing deficit in a patient with Lewy body dementia: a case report

Montalvo A, Azevedo E, de Mendonça A.

J Med Case Rep. 2021 Sep 9;15(1):449. doi: 10.1186/s13256-021-03039-2.

Cognitive Impairment in Older Adults and Therapeutic Strategies

Montine TJ, Bukhari SA, White LR.

Pharmacol Rev. 2021 Jan;73(1):152-162. doi: 10.1124/pharmrev.120.000031.

Coronavirus disease 2019 and neurodegenerative disease: what will the future bring?

McAlpine LS, Fesharaki-Zadeh A, Spudich S.

Curr Opin Psychiatry. 2021 Mar 1;34(2):177-185. doi: 10.1097/YCO.0000000000000688.

Hyperhomocysteinemia and Dementia Associated With Severe Cortical Atrophy, but No Amyloid Burden

Reffo A, Gabelli C.

J Geriatr Psychiatry Neurol. 2022 Jan;35(1):57-61. doi: 10.1177/0891988720988910. Epub 2021 Jan 19.

Prevalence and Associated Factors of Visual Hallucinations in Patients with Vascular Cognitive Impairment

Chen CL, Hsu MH, Hung CH, Chiu PY, Liu CH.

Behav Neurol. 2021 Jan 9;2021:8866763. doi: 10.1155/2021/8866763. eCollection 2021.

Cerebrospinal fluid N-224 tau helps discriminate Alzheimer's disease from subjective cognitive decline and other dementias

Cicognola C, Hansson O, Scheltens P, Kvartsberg H, Zetterberg H, Teunissen CE, Blennow K.

Alzheimers Res Ther. 2021 Feb 8;13(1):38. doi: 10.1186/s13195-020-00756-6.

The pleiotropic neuroprotective effects of resveratrol in cognitive decline and Alzheimer's disease pathology: From antioxidant to epigenetic therapy

Griñán-Ferré C, Bellver-Sanchis A, Izquierdo V, Corpas R, Roig-Soriano J, Chillón M, Andres-Lacueva C, Somogyvári M, Sőti C, Sanfeliu C, Pallàs M.

Ageing Res Rev. 2021 May;67:101271. doi: 10.1016/j.arr.2021.101271. Epub 2021 Feb 8.

Targeting impaired nutrient sensing with repurposed therapeutics to prevent or treat age-related cognitive decline and dementia: A systematic review

Kioussis B, Tuttle CSL, Heard DS, Kennedy BK, Lautenschlager NT, Maier AB.

Ageing Res Rev. 2021 May;67:101302. doi: 10.1016/j.arr.2021.101302. Epub 2021 Feb 17.

The Efficacy of Ketogenic Therapies in the Clinical Management of People with Neurodegenerative Disease: A Systematic Review

Dewsbury LS, Lim CK, Steiner GZ.

Adv Nutr. 2021 Jul 30;12(4):1571-1593. doi: 10.1093/advances/nmaa180.

Contextual Processing and the Impacts of Aging and Neurodegeneration: A Scoping Review

Tran KH, McDonald AP, D'Arcy RCN, Song X.

Clin Interv Aging. 2021 Feb 24;16:345-361. doi: 10.2147/CIA.S287619. eCollection 2021.

A Scoping Review of Neuromodulation Techniques in Neurodegenerative Diseases: A Useful Tool for Clinical Practice?

Marson F, Lasaponara S, Cavallo M.

Medicina (Kaunas). 2021 Feb 27;57(3):215. doi: 10.3390/medicina57030215.

Mechanistic insights into the pathogenesis of neurodegenerative diseases: towards the development of effective therapy

Nazam F, Shaikh S, Nazam N, Alshahrani AS, Hasan GM, Hassan MI.

Mol Cell Biochem. 2021 Jul;476(7):2739-2752. doi: 10.1007/s11010-021-04120-6. Epub 2021 Mar 9.

Neuroticism and Risk of Parkinson's Disease: A Meta-Analysis

Terracciano A, Aschwanden D, Stephan Y, Cerasa A, Passamonti L, Toschi N, Sutin AR.

Mov Disord. 2021 Aug;36(8):1863-1870. doi: 10.1002/mds.28575. Epub 2021 Apr 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias